<DOC>
	<DOC>NCT01005823</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of 7 days treatment with LEO 29102 in adult patients with atopic dermatitis.</brief_summary>
	<brief_title>A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Age 1855 years Atopic dermatitis of 8501700cm2 In good health Criteria for exclusion: Comorbid conditions Hepatic dysfunction Clinical infection Immunocompromised status Clinically significant illness Use of immunomodulating treatment Medications related to respiratory system or to heart rhythm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>